FOLASHADE KANIMODO: Open Payments
NPI 1417174889 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$988 in 10 payments from 9 companies in 2025. Trend: 2023 $546 · 2024 $277 · 2025 $988
Food & beverage: $988
| Company | Payments | Amount |
|---|---|---|
| Hologic Sales and Service, LLC | 2 | $213 |
| Novo Nordisk Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| Neurocrine BioSciences, Inc. | 1 | $120 |
| Sage Therapeutics, LLC | 1 | $99 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $97 |
| COLOPLAST CORP | 1 | $76 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: APTIMA, Wegovy, VOQUEZNA, INGREZZA, Titan, CAPLYTA.
Industry payments across MD — which companies pay providers there.
